Updated Deadline, 2 Days Left! Submit your application today to be part of the First Ever Diabetes Innovation Challenge.


The Diabetes Innovation Challenge is brought to you by the T1D Exchange and the Massachusetts Medical Device Development Center (M2D2) at UMass. The Challenge offers medical device and biotech entrepreneurs the chance to win in-kind awards and receive critical early and later-stage validation of their ideas and products specific to Type 1 and Type 2 diabetes. The Diabetes Innovation Challenge is a proposal- and presentation-based competition for small companies in the T1 and T2 space that are making real progress towards better outcomes for those diagnosed.

The world needs more effective, functional and affordable technology solutions for Type 1 and Type 2 diabetes. With the Diabetes Innovation Challenge, we encourage entrepreneurs to bring forth technologies that address these real clinical needs.

Competition entries are judged on:

  • Technical, economic and regulatory feasibility
  • Contribution to the health and quality of life for those living with Type 1 and Type 2 diabetes
  • Technological innovation
  • Potential for commercialization


July 21, 2016 –  Deadline to submit initial applications for the 2016 Diabetes Innovation Challenge
July. 29, 2016 – Notification to initial applicants; those selected to advance will receive additional information and instructions
Sept. 29, 2016 – Semi-Finals: In-person presentations at the UMass Medical School in Worcester for qualified translational project applicants
Oct. 5, 2016 – Semi-Finals: In-person presentations at UMass Lowell for qualified early stage project applicants
Oct. 20, 2016
  • Finals: Up to six early stage project applicants will present to panel of judges at Royal Sonesta Boston
  • Finals: Up to six translational project applicants will present to panel of judges at Royal Sonesta Boston
  • Up to 20 noteworthy applicants will be offered poster presentation space at Royal Sonesta Boston

Oct. 21, 2016 – Up to two awardees will be invited to present at T1D Exchange’s 2016 Innovations in Care meeting.


Diabetes Innovaition Challenge Logo

Abigail Ballou

Abigail Ballou

    Abby Ballou is the managing editor of MedTech Boston. She has a B.A. and M.Phil in English literature from NYU and the CUNY Graduate Center, respectively. When she isn't writing and editing for MedTech Boston, Abby enjoys reading, rock climbing, watching classic movies and listening to opera.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Follow us!

    Send this to friend